Quality of glucose measurement with blood glucose meters at the point-of-care: Relevance of interfering factors

Diabetes Technology and Therapeutics

Volumn 12, Issue 11, 2010, Pages 847-857

  Heinemann, Lutz ^a,b  

^a Profil Institut fur Stoffwechselforschung GmbH   (Germany)

^b Profil Institute for Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MALTOSE; PARACETAMOL; PERITONEAL DIALYSIS FLUID;

ACCURACY; ALTITUDE; BIOSENSOR; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; ENVIRONMENTAL FACTOR; ENZYME MECHANISM; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PATIENT EDUCATION; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REVIEW; SELF MONITORING; TEMPERATURE SENSITIVITY; TEST STRIP;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DRUG INTERACTIONS; GLUCOSE 1-DEHYDROGENASE; GLUCOSE OXIDASE; HUMANS; OXYGEN; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REAGENT STRIPS; REPRODUCIBILITY OF RESULTS;

EID: 78649386363     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0076     Document Type: Review

References (46)

1. Olansky L, Kennedy L: Finger-stick glucose monitoring: issues of accuracy and specificity. Diabetes Care 2010;33:948-949.
2. Freckmann G, Baumstark A, Jendrike N, Zschornack E, Kocher S, Tshiananga J, Heister F, Haug C: System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 2010; 12:221-231.
3. Frias JP, Lim CG, Ellison JM, Montandon CM: Review of adverse events associated with false glucose readings measured by GDH-PQQ-based glucose test strips in the presence of interfering sugars. Diabetes Care 2010;33:728-729.
4. United States Renal Data System, Annual Data Report, Reference Tables. 2009. www.usrds.org/2007/pdf/04- modalities-07.pdf (accessed June 30, 2008).
5. Baxter Healthcare Corp.: Extraneal (Icodextrin) Peritoneal Dialysis Solution. 2006. www.baxter.com/products/renal/downloads/extraneal-pi.pdf (accessed June 30, 2008).
6. Octapharma Pharmazeutika: Octagam® 5%, 2005. www. fda.gov/cber/label/igivoct020306LB.pdf (accessed June 30, 2008).
7. Cangene Corp.: Rh0 (D) Immune Globulin, Intravenous (Human), WinRho® SDF. 2008. www.winrho.com/pdfs/WinRhoPI.pdf (accessed June 30, 2008).
8. Bristol-Myers Squibb Co.: Orencia® (abatacept). 2008. packageinserts.bms.com/pi/pi-orencia.pdf (accessed June 30, 2008).
9. Food and Drug Administration: Drugs@FDA; Drug Details. 2008. accessdata.fda.gov/scripts/cder/drugsat fda/index. cfm (accessed June 30, 2008).
10. Baxter Healthcare Corp.: Adept®, Adhesion Reduction Solution (4% Icodextrin). 2008. www.baxter.com/products/biopharmaceuticals/downloads/Adept- IFU.pdf (accessed June 30, 2008).
11. Food and Drug Administration: FDA New Device Approval. 2006. www.fda.gov/cdrh/mda/docs/p050011.html (accessed June 30, 2008).
12. Cangene Corp.: HepaGam B® (Hepatitis B Immune Globulin Intravenous [Human]). 2007. www.hepagamb.com/Files/HepagamBPI.pdf (accessed June 30, 2008).
13. GlaxoSmithKline: Bexxar® (Tositumomab and Iodine I 131 Tositumomab). 2005 us.gsk.com/products/assets/us-bexxar. pdf (accessed June 30, 2008).
14. Schleis TG: Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 2007;27:1313-1321.
15. Ghys T, Goedhuys W, Spincemaille K, Gorus F, Gerlo E: Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters. Clin Chim Acta 2007;386:63-68.
16. Boenitz-Dulat M, Laggerbauer J, Schmuck R, Kratszch R, Kanppe W-R, inventors; Roche Diagnostics GmbH, F. Hoffmann-La Roche AG, applicants: Genetically engineered pyrroloquinoline quinone-dependent glucose dehydrogenase comprising an amino acid insertion. Publication number WO/2006/008132. International Patent Application PCT/EP2005/007844. July 19, 2005.
17. Kratzsch P, Schmuck R, Bunk D, Shao Z, Thym D, Knappe W-R, inventors; Roche Diagnostics GmbH, F. Hoffmann-La Roche AG, applicants: Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase. Publication number WO/2002/034919. International Patent Application PCT/EP2001/012148. October 20, 2002.
18. rd ed. Brussels: International Diabetes Federation, 2006.
19. Bamberg R, Schulman K, MacKenzie M, Moore J, Olchesky S: Effect of adverse storage conditions on performance of glucometer test strips. Clin Lab Sci 2005;18:203-209.
20. Bilen H, Kilicaslan A, Akcay G, Albayrak F: Performance of glucose dehydrogenase (GDH) based and glucose oxidase (GOX) based blood glucose meter systems at moderately high altitude. J Med Eng Technol 2007;31:152-156.
21. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V: Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008;83:400-405.
22. Devreese K, Leroux-Roels G: Laboratory assessment of five glucose meters designed for self-monitoring of blood glucose concentration. Eur J Clin Chem Clin Biochem 1993;31:829-837. (Pubitemid 24015309)
23. Eastham JH, Mason D, Barnes DL, Kollins J: Prevalence of interfering substances with point-of-care glucose testing in a community hospital.AmJHealth Syst Pharm 2009;66:167-170.
24. Fink KS, Christensen DB, Ellsworth A: Effect of high altitude on blood glucose meter performance. Diabetes Technol Ther 2002;4:627-635.
25. Floré K, Delanghe J: Icodextrin: a major problem for glucose dehydrogenase-based glucose point of care testing systems. Acta Clin Belg 2006;61:351-354.
26. Forrow NJ, Bayliff SW: A commercial whole blood glucose biosensor with a low sensitivity to hematocrit based on an impregnated porous carbon electrode. Biosens Bioelectron 2005;21:581-587.
27. Giordano BP, Thrash W, Hollenbaugh L, Dube WP, Hodges C, Swain A, Banion CR, Klingensmith GJ: Performance of seven blood glucose testing systems at high altitude. Diabetes Educ 1989;15:444-448.
28. Gutman SI, Fuller JG, Hausman ED: Consumers report glucose meter problems to FDA. Diabetes Technol Ther 2004;6:767-769.
29. Hoftman N: Interference between Extraneal peritoneal dialysis and the Accu-Chek blood glucose monitor. Anesthe-siology 2005;102:871.
30. Hussain K, Sharief N: The inaccuracy of venous and capillary blood glucose measurement using reagent strips in the newborn period and the effect of haematocrit. Early Hum Dev 2000;57:111-121.
31. Kannan S, Rowland CH, Hockings GI, Tauchmann PM: In-tragam can interfere with blood glucose monitoring. Med J Aust 2004;180:251-252.
32. Louie RF, Tang Z, Sutton, DV, Lee JH, Kost GJ: Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med 2000;124:257-266.
33. Mehmet S, Quan G, Thomas S, Goldsmith D: Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis. Diabet Med 2001;18:679-682.
34. Michel A, Kuster H, Krebs A, Kadow I, Paul W, Nauck M, Fusch C: Evaluation of the Glucometer Elite XL device for screening for neonatal hypoglycaemia. Eur J Pediatr 2005;164:660-664.
35. Moatti-Sirat D, Poitout V, Thome V, Gangnerau MN, Zhang Y, Hu Y, Wilson GS, Lemonnier F, Klein JC, Reach G Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man. Diabetologia 1994;37:610-616.
36. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, Reynolds R, Ogrinc F, Martis L, Wolfson M: Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002;(81):S23-S33.
37. Montagnana M, Caputo M, Giavarina D, Lippi G: Overview on self-monitoring of blood glucose. Clin Chim Acta 2009;402:7-13.
38. Nawawi H, Sazali BS, Kamaruzaman BH, Yazid TN, Jemain AA, Ismail F, Khalid BA: Effect of ambient temperature on analytical and clinical performance of a blood glucose monitoring system: Omnitest Sensor glucose meter. Ann Clin Biochem 2001;38:676-683.
39. Pecchio O, Maule S, Migliardi M, Trento M, Veglio M: Effects of exposure at an altitude of 3,000m on performance of glucose meters. Diabetes Care 2000;23:129-131.
40. Rice GK, Galt KA: In vitro drug interference with home blood-glucose-measurement systems. Am J Hosp Pharm 1985;42:2202-2207.
41. Tang Z, Du X, Louie RF, Kost GJ: Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol 2000;113:75-86. (Pubitemid 30217342)
42. Updike SJ, Shults MC, Capelli CC, von HD, Rhodes RK, Joseph-Tipton N, Anderson B, Koch DD: Laboratory evaluation of new reusable blood glucose sensor. Diabetes Care 1988;11:801-807.
43. Vote DA, Doar O, Moon RE, Toffaletti JG: Blood glucose meter performance under hyperbaric oxygen conditions. Clin Chim Acta 2001;305:81-87.
44. Wiener K: The effect of haematocrit and sample temperature on the Glucotide/Glucometer 4 blood glucose assay system. Diabet Med 1995;12:362-363.
45. Directive 98/79/EC on In Vitro Medical Devices. Berlin: European Commission, 1998.
46. DIN EN ISO 15197: In Vitro Diagnostic Test Systems\Requirements for Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus (ISO 15197:2003). Berlin: Beuth Verlag GmbH, 2003.